INTERNATIONAL PATENT: PALLEON PHARMACEUTICALS INC. FILES APPLICATION FOR "RECOMBINANT HUMAN SIALIDASES, SIALIDASE FUSION PROTEINS AND METHODS OF USING THE SAME"

GENEVA, Oct. 20 -- PALLEON PHARMACEUTICALS INC. (266 Second Avenue, 2nd FloorWaltham, Massachusetts 02451) filed a patent application (PCT/US2025/023613) for "RECOMBINANT HUMAN SIALIDASES, SIALIDASE FUSION PROTEINS, AND METHODS OF USING THE SAME" on Apr 08, 2025. With publication no. WO/2025/217138, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KEMP, Michael (266 Second Avenue, 2nd FloorWaltham, Massachusetts 02451), CAO, Lizhi (266 Second Avenue, 2nd FloorWaltham, Massachusetts 02451), PENG, Li (266 Second Avenue, 2nd ...